A Novel Chimeric Lysin Shows Superiority to Mupirocin for Skin Decolonization of Methicillin-Resistant and -SensitiveStaphylococcus aureusStrains

Synergism between a Novel Chimeric Lysin and Oxacillin Protects against Infection by Methicillin-Resistant Staphylococcus aureus

(2010) A. Daniel et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Preventing Surgical-Site Infections in Nasal Carriers ofStaphylococcus aureus

(2010) Lonneke G.M. Bode et al.   NEW ENGLAND JOURNAL OF MEDICINE

Mupirocin application at the exit site in peritoneal dialysis patients: five years of experience

(2010) Sifil Aykut et al.   RENAL FAILURE

Eradication of Methicillin‐ResistantStaphylococcus aureusCarriage: A Systematic Review

(2009) Heidi S. M. Ammerlaan et al.   CLINICAL INFECTIOUS DISEASES

Mupirocin Resistance

(2009) Jean B. Patel et al.   CLINICAL INFECTIOUS DISEASES

Topical Therapy for Methicillin-Resistant Staphylococcus aureus Colonization Impact on Infection Risk

(2009) Ari Robicsek et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Nasal decolonization of Staphylococcus aureus with mupirocin: strengths, weaknesses and future prospects

(2009) T. Coates et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Mupirocin for preventing exit-site infection and peritonitis in patients undergoing peritoneal dialysis

(2009) G. Xu et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Bacteriophage lysins as effective antibacterials

(2008) Vincent A Fischetti   CURRENT OPINION IN MICROBIOLOGY

Surveillance for Mupirocin Resistance Among Methicillin-Resistant Staphylococcus aureus Clinical Isolates

(2008) Kanokporn Mongkolrattanothai et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY